CDR2 and CDR2L Line Blot Performance in PCA-1/Anti-Yo Paraneoplastic Autoimmunity

ObjectiveTo compare the performance of cerebellar degeneration-related protein 2 (CDR2) and CDR2-like (CDR2L) antigens in a line blot format.

Authors

Publication Details

Journal
Neurology
Published
2024-10-08
DOI
https://doi.org/10.1212/01.wnl.0001051216.12547.c0
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CDR2 and CDR2L Line Blot Performance in PCA-1/Anti-Yo Paraneoplastic Autoimmunity

Αναστασία Ζεκερίδου, Divyanshu Dubey, Nisa Vorasoot, Smathorn Thakolwiboon et al.
Neurology
Cancer Immunotherapy and Biomarkers
article

CDR2 and CDR2L Line Blot Performance in PCA-1/Anti-Yo Paraneoplastic Autoimmunity

Αναστασία Ζεκερίδου, Divyanshu Dubey, Nisa Vorasoot, Smathorn Thakolwiboon, Andrew B. McKeon, Ramona Miske, Anthonina Ott, John Mills, Madeleine Scharf, Sean J Pittock
article en

Abstract

ObjectiveTo compare the performance of cerebellar degeneration-related protein 2 (CDR2) and CDR2-like (CDR2L) antigens in a line blot format.

NeurologyVol. 103(7_Supplement_1)
Zero hunger
Openalex Percentile: Top 69%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.